Spotlight series: How HBP scientists and infrastructures help in the Corona crisis

    29 April 2020


    The Corona crisis is a major threat to society and an urgent challenge to science. In this situation, researchers throughout the Human Brain Project (HBP) use their expertise and unique scientific infrastructure to address research questions that go beyond neuroscience, to support activities against the pandemic.  For this series we highlight some of the work.

     

    News

     

    Fenix Resources for COVID-19 research

    For researchers and scientists working on topics related to the current COVID-19 pandemic the Fenix Research Infrastructures provides consultancy support and help for getting access to powerful supercomputing resources.

    Fenix is a distributed infrastructure providing High Performance computing, cloud and data resources to European research and scientists. The resources are provided by five European supercomputing centres, namely BSC (Spain), CEA (France), CINECA (Italy), CSCS (Switzerland) and JSC (Germany). They are being made available through the Human Brain Project and PRACE. Resources are ready for allocations at short notice.

    Read more

     

    Interviews

     

    Combating the coronavirus with computational modelling

    Prof. Paolo Carloni and Jr Prof. Giulia Rossetti

    Institution: HBP partner Forschungszentrum Jülich

    HBP research areas: Molecular Neuroscience

    Read more

     

    Could nicotine help against Covid-19?

    Prof. Jean-Pierre Changeux

    Institution: HBP partner Institut Pasteur

    HBP research areas: Molecular Neuroscience

    Read more

     

    Katrin Amunts and Bertrand Thirion are advising their Governments

    Prof. Dr. med. Katrin Amunts and Bertrand Thirion

    Institution: Forschungszentrum Jülich and INRIA

    HBP research areas: HBP Scientific Director and Task Leader Human Brain Organization

    Read more

     

    Data science against Covid-19

    Prof. Dr. Martin Hofmann-Apitius

    Institution: Fraunhofer Institute for Algorithms and Scientific Computing SCAI

    HBP research areas: Medical Informatics Platform

    Read more

     

    High Performance Computing to model disease spread

    Prof. Dr. Thomas Lippert

    Institution: Director of Jülich Supercomputing Centre, Germany

    HBP research areas: Leader of HBPs High Performance Computing and Analytics platform

    Read more

     

    Hunting for the molecular Achilles heel of Sars-CoV-2

    Prof. Rebecca Wade

    Institution: Heidelberg Institute for Theoretical Studies

    HBP research areas:  Molecular modeling and simulation

    Read more

     

    Further activities

     

    Integrating psychosocial variables and societal diversity in epidemic models for predicting COVID-19 transmission dynamics

    Prof. Viktor Jirsa

    HBP research areas: Modeling

    By causally linking an established epidemiological spread model with dynamically evolving psychosocial variables, researchers have demonstrated that the strength of cumulative influence of psychosocial variables on infection rates is of a similar magnitude as the influence of physical distancing. They further show that the efficacy of political interventions to contain the disease strongly depends on societal diversity, in particular group-specific sensitivity to affective risk perception. As a consequence, the model may assist in quantifying the effect and timing of interventions, forecasting future scenarios, and differentiating the impact on diverse groups as a function of their societal organization.

    Read more
     

    Single-cell analysis of COVID-19 infected individuals

    Dr. Marc Beyer

    Institution: HBP partner Deutsches Zentrum fuer Neurodegenerative Erkrankungen e.V. (DZNE)

    HBP research areas: Molecular Immunology

    The group of Dr. Beyer is highly interested in unraveling the molecular events in innate and adaptive immune cells. His team is performing single-cell analysis of COVID-19 infected individuals at the DZNE Institute.

    Read more about DZNE activities against COVID-19 here and here.


    Academic Resources platform for COVID-19 in Switzerland

    Prof. Felix Schuermann

    Institution: HBP partner École polytechnique fédérale de Lausanne (EPFL)

    HBP research areas: Brain Simulation, Modeling

    The Blue Brain project is collaborating on an online platform, Academic Resources for COVID-19 (ARC), to support Switzerland's diagnostic laboratories to perform an adequate number of daily tests for COVID-19 as lockdown eases. The team have also used their expertise in data modelling to develop The Diagnostic Implementation Simulator for SARS-CoV-2, which can estimate the potential impact of deploying different test strategies for COVID-19.

    Read more about EPFL activities against COVID-19.


    Effects of COVID-19 lockdown on mental health

    Prof. Gunter Schumann

    Institution: HBP partner King's College London

    HBP research areas: Medicine, Mental disorders

    Prof. Gunter Schumann and his team at King's College London are investigating how the social isolation resulting from lockdown during the COVID-19 pandemic influences behaviour and mental health in young people in Europe, India, China, and the United States.

    Read more about King's College London activities against COVID-19.


    Modeling to estimate the number of hospital beds needed in Sweden

    Prof. Jeanette Hellgren Kotaleski, Dr. Andrei Kramer, Dr. Olivia Eriksson

    Institution: HBP partner Kungliga Tekniska Hoegskolan (KTH)

    HBP research areas: Modeling

    The KTH group has been asked to help to model the spread of COVID-19 in Sweden to predict the number of intensive care unit beds that would be required in different hospitals across the country. The workflow involves data collection and sensitivity analysis on the predictions. A similar modelling workflow will be used in SGA3 which collects relevant information needed for building, optimising, and simulating subcellular models in one place.

    Read more about Kungliga Tekniska Hoegskolan activities against COVID-19.